Regulation and licensing: the CRISPR conundrum continues

In January 2018, The Wall Street Journal issued a fascinating report into clinical trials in China. Since 2015, the report said, scientists have used the now well-known CRISPR technology on at least 86 cancer patients. China is believed to be the first country in the world to test CRISPR on humans. According to doctors quoted in the article, 15 patients had died during the trials, but those deaths were caused by the diseases they were suffering from.